Home > Investors
 
Mission & Goals
IR Agenda
Investor Updates
Presentations & Events
Pharma Pipeline
Diagnostics Products
Figures & Reports
Finance Info System
Share Information
Bond Information
Corporate Governance
Annual General Meeting
Company Background
Document Centre
Contacts

Roche for Investors
Share Information:

Displayed market data delayed 20 min
 
Roche’s Offer for Genentech

Investor Feedback
Please take a moment to complete our Investors Survey

Corporate Overview for Investors

Download PDF
Latest Investor Updates:
  31 July 2008
  Full reconciliation of Chugai interim results into IFRS 
  31 July 2008
  Toll Manufacturing Agreement for the Bulk Drug Substance of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody 
  31 July 2008
  MabThera filed in the EU for treatment of most common leukaemia in adults 

Events:

28 July 2008
Roche Investor event, AACC 2008

21 July 2008
Half Year Results for 2008

13 June 2008
Roche investor science event, EULAR

9 June 2008
Roche investor science event, ADA

May 30 - June 3 2008
ASCO Annual Meeting
 
Deutsche Sprachversion     

English Version     
  
© 1996-2008 F.Hoffmann-La Roche Ltd - Legal Statement - Privacy Policy